Vildagliptin
Back to searchMolecule Structure
Scientific Name
Vildagliptin
Description of the Drug
Vildagliptin is a once-daily dipeptidyl peptidase 4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04876
http://www.drugbank.ca/drugs/DB04876
Brand Name(s)
Galvus
Company Owner(s)
Not Available
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dipeptidyl peptidase IV | SINGLE PROTEIN | INHIBITOR | CHEMBL284 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL16579 | |||||
PharmGKB | PA165958346 | |||||
Human Metabolome Database | HMDB0015596 | |||||
DrugBank | DB04876 | |||||
PubChem: Thomson Pharma | 14849686 | 14898545 | ||||
PubChem | 6918537 | |||||
BindingDB | 11695 | |||||
EPA CompTox Dashboard | DTXSID80881091 | |||||
DrugCentral | 3642 | |||||
Brenda | 64118 | 25034 | 75289 | 39902 | 151480 | 58976 |
ChemicalBook | CB71449010 | |||||
Guide to Pharmacology | 6310 | |||||
rxnorm | VILDAGLIPTIN | |||||
PubChem: Drugs of the Future | 12015446 | |||||
ChEBI | 135285 |